4//SEC Filing
KYTHERA BIOPHARMACEUTICALS INC 4
Accession 0001104659-15-068856
CIK 0001436304operating
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 2:15 PM ET
Size
14.0 KB
Accession
0001104659-15-068856
Insider Transaction Report
Form 4
Kress Francois
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2015-10-01−6,618→ 0 totalExercise: $21.65Exp: 2023-06-04→ Common Stock (6,618 underlying) - Disposition to Issuer
Stock Option (right to buy)
2015-10-01−5,672→ 0 totalExercise: $16.00Exp: 2022-10-10→ Common Stock (5,672 underlying) - Disposition to Issuer
Stock Option (right to buy)
2015-10-01−11,591→ 0 totalExercise: $53.26Exp: 2025-06-02→ Common Stock (11,591 underlying) - Disposition to Issuer
Stock Option (right to buy)
2015-10-01−18,908→ 0 totalExercise: $5.90Exp: 2020-12-09→ Common Stock (18,908 underlying) - Disposition to Issuer
Stock Option (right to buy)
2015-10-01−8,400→ 0 totalExercise: $33.26Exp: 2024-06-05→ Common Stock (8,400 underlying)
Footnotes (1)
- [F1]Disposed of pursuant to the Amended and Restated Agreement and Plan of Merger dated as of August 4, 2015, by and among Allergan plc (formerly known as Actavis plc) ("Allergan"), Keto Merger Sub, Inc. (a wholly owned subsidiary of Allergan) and Issuer, whereby each option to purchase common stock was cancelled and paid in cash assuming a stock price of $75.00.
Documents
Issuer
KYTHERA BIOPHARMACEUTICALS INC
CIK 0001436304
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001436304
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 2:15 PM ET
- Size
- 14.0 KB